Figure 2 Meta-analysis of the use of angiotensin converting enzyme (ACE) inhibitors on pneumonia risk. The use of ACE inhibitors was associated with a significant 27% reduction of pneumonia risk compared with controls (OR: 0.73, 95% CI: 0.64 to 0.83; p<0.001).